PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Miyagi, Japan.\', \'Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: skutsuna@hosp.ncgm.go.jp.\', \'Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.\', \'Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Miyagi, Japan; Antimicrobial Resistance Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.\', \'Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1341-321X(21)00012-X10.1016/j.jiac.2021.01.004
?:doi
?:hasPublicationType
?:journal
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33487533
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all